COVID-19 Impact on Global Adoptive Cellular Immunotherapy Market Size, Status and Forecast 2020-2026

COVID-19 Impact on Global Adoptive Cellular Immunotherapy Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Adoptive Cellular Immunotherapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Adoptive Cellular Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 TIL
1.4.3 LAK
1.4.4 CAR-T
1.4.5 TCR-T
1.4.6 CIK
1.4.7 NK
1.4.8 DC
1.4.9 Other
1.5 Market by Application
1.5.1 Global Adoptive Cellular Immunotherapy Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Cancer Hospital
1.5.4 Centers for Disease Control and Prevention
1.5.5 Rehabilitation Center
1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Adoptive Cellular Immunotherapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Adoptive Cellular Immunotherapy Industry
1.6.1.1 Adoptive Cellular Immunotherapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Adoptive Cellular Immunotherapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Adoptive Cellular Immunotherapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Adoptive Cellular Immunotherapy Market Perspective (2015-2026)
2.2 Adoptive Cellular Immunotherapy Growth Trends by Regions
2.2.1 Adoptive Cellular Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Adoptive Cellular Immunotherapy Historic Market Share by Regions (2015-2020)
2.2.3 Adoptive Cellular Immunotherapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Adoptive Cellular Immunotherapy Market Growth Strategy
2.3.6 Primary Interviews with Key Adoptive Cellular Immunotherapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cellular Immunotherapy Players by Market Size
3.1.1 Global Top Adoptive Cellular Immunotherapy Players by Revenue (2015-2020)
3.1.2 Global Adoptive Cellular Immunotherapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Adoptive Cellular Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Adoptive Cellular Immunotherapy Market Concentration Ratio
3.2.1 Global Adoptive Cellular Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Adoptive Cellular Immunotherapy Revenue in 2019
3.3 Adoptive Cellular Immunotherapy Key Players Head office and Area Served
3.4 Key Players Adoptive Cellular Immunotherapy Product Solution and Service
3.5 Date of Enter into Adoptive Cellular Immunotherapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Adoptive Cellular Immunotherapy Historic Market Size by Type (2015-2020)
4.2 Global Adoptive Cellular Immunotherapy Forecasted Market Size by Type (2021-2026)
5 Adoptive Cellular Immunotherapy Breakdown Data by Application (2015-2026)
5.1 Global Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)
5.2 Global Adoptive Cellular Immunotherapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Adoptive Cellular Immunotherapy Market Size (2015-2020)
6.2 Adoptive Cellular Immunotherapy Key Players in North America (2019-2020)
6.3 North America Adoptive Cellular Immunotherapy Market Size by Type (2015-2020)
6.4 North America Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Adoptive Cellular Immunotherapy Market Size (2015-2020)
7.2 Adoptive Cellular Immunotherapy Key Players in Europe (2019-2020)
7.3 Europe Adoptive Cellular Immunotherapy Market Size by Type (2015-2020)
7.4 Europe Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)
8 China
8.1 China Adoptive Cellular Immunotherapy Market Size (2015-2020)
8.2 Adoptive Cellular Immunotherapy Key Players in China (2019-2020)
8.3 China Adoptive Cellular Immunotherapy Market Size by Type (2015-2020)
8.4 China Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Adoptive Cellular Immunotherapy Market Size (2015-2020)
9.2 Adoptive Cellular Immunotherapy Key Players in Japan (2019-2020)
9.3 Japan Adoptive Cellular Immunotherapy Market Size by Type (2015-2020)
9.4 Japan Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Adoptive Cellular Immunotherapy Market Size (2015-2020)
10.2 Adoptive Cellular Immunotherapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Adoptive Cellular Immunotherapy Market Size by Type (2015-2020)
10.4 Southeast Asia Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)
11 India
11.1 India Adoptive Cellular Immunotherapy Market Size (2015-2020)
11.2 Adoptive Cellular Immunotherapy Key Players in India (2019-2020)
11.3 India Adoptive Cellular Immunotherapy Market Size by Type (2015-2020)
11.4 India Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Adoptive Cellular Immunotherapy Market Size (2015-2020)
12.2 Adoptive Cellular Immunotherapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Adoptive Cellular Immunotherapy Market Size by Type (2015-2020)
12.4 Central & South America Adoptive Cellular Immunotherapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Amgen Inc
13.1.1 Amgen Inc Company Details
13.1.2 Amgen Inc Business Overview and Its Total Revenue
13.1.3 Amgen Inc Adoptive Cellular Immunotherapy Introduction
13.1.4 Amgen Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020))
13.1.5 Amgen Inc Recent Development
13.2 Autolus Therapeutics Plc
13.2.1 Autolus Therapeutics Plc Company Details
13.2.2 Autolus Therapeutics Plc Business Overview and Its Total Revenue
13.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Introduction
13.2.4 Autolus Therapeutics Plc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
13.2.5 Autolus Therapeutics Plc Recent Development
13.3 Beijing Immunochina Medical Science & Technology Co Ltd
13.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
13.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview and Its Total Revenue
13.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
13.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
13.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
13.4 Bellicum Pharmaceuticals Inc
13.4.1 Bellicum Pharmaceuticals Inc Company Details
13.4.2 Bellicum Pharmaceuticals Inc Business Overview and Its Total Revenue
13.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Introduction
13.4.4 Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
13.4.5 Bellicum Pharmaceuticals Inc Recent Development
13.5 Bristol-Myers Squibb Co
13.5.1 Bristol-Myers Squibb Co Company Details
13.5.2 Bristol-Myers Squibb Co Business Overview and Its Total Revenue
13.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Introduction
13.5.4 Bristol-Myers Squibb Co Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
13.5.5 Bristol-Myers Squibb Co Recent Development
13.6 bluebird bio Inc
13.6.1 bluebird bio Inc Company Details
13.6.2 bluebird bio Inc Business Overview and Its Total Revenue
13.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Introduction
13.6.4 bluebird bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
13.6.5 bluebird bio Inc Recent Development
13.7 CARsgen Therapeutics Ltd
13.7.1 CARsgen Therapeutics Ltd Company Details
13.7.2 CARsgen Therapeutics Ltd Business Overview and Its Total Revenue
13.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Introduction
13.7.4 CARsgen Therapeutics Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
13.7.5 CARsgen Therapeutics Ltd Recent Development
13.8 Celgene Corp
13.8.1 Celgene Corp Company Details
13.8.2 Celgene Corp Business Overview and Its Total Revenue
13.8.3 Celgene Corp Adoptive Cellular Immunotherapy Introduction
13.8.4 Celgene Corp Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
13.8.5 Celgene Corp Recent Development
13.9 Cell Medica Ltd
13.9.1 Cell Medica Ltd Company Details
13.9.2 Cell Medica Ltd Business Overview and Its Total Revenue
13.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Introduction
13.9.4 Cell Medica Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
13.9.5 Cell Medica Ltd Recent Development
13.10 Cellular Biomedicine Group Inc
13.10.1 Cellular Biomedicine Group Inc Company Details
13.10.2 Cellular Biomedicine Group Inc Business Overview and Its Total Revenue
13.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Introduction
13.10.4 Cellular Biomedicine Group Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
13.10.5 Cellular Biomedicine Group Inc Recent Development
13.11 Celularity Inc
10.11.1 Celularity Inc Company Details
10.11.2 Celularity Inc Business Overview and Its Total Revenue
10.11.3 Celularity Inc Adoptive Cellular Immunotherapy Introduction
10.11.4 Celularity Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.11.5 Celularity Inc Recent Development
13.12 Celyad SA
10.12.1 Celyad SA Company Details
10.12.2 Celyad SA Business Overview and Its Total Revenue
10.12.3 Celyad SA Adoptive Cellular Immunotherapy Introduction
10.12.4 Celyad SA Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.12.5 Celyad SA Recent Development
13.13 Daiichi Sankyo Co Ltd
10.13.1 Daiichi Sankyo Co Ltd Company Details
10.13.2 Daiichi Sankyo Co Ltd Business Overview and Its Total Revenue
10.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Introduction
10.13.4 Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.13.5 Daiichi Sankyo Co Ltd Recent Development
13.14 Fosun Pharmaceutical AG
10.14.1 Fosun Pharmaceutical AG Company Details
10.14.2 Fosun Pharmaceutical AG Business Overview and Its Total Revenue
10.14.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Introduction
10.14.4 Fosun Pharmaceutical AG Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.14.5 Fosun Pharmaceutical AG Recent Development
13.15 Gilead Sciences Inc
10.15.1 Gilead Sciences Inc Company Details
10.15.2 Gilead Sciences Inc Business Overview and Its Total Revenue
10.15.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Introduction
10.15.4 Gilead Sciences Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.15.5 Gilead Sciences Inc Recent Development
13.16 Guangzhou Anjie Biomedical Technology Co Ltd
10.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details
10.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview and Its Total Revenue
10.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
10.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
13.17 Hangzhou Converd Co Ltd
10.17.1 Hangzhou Converd Co Ltd Company Details
10.17.2 Hangzhou Converd Co Ltd Business Overview and Its Total Revenue
10.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Introduction
10.17.4 Hangzhou Converd Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.17.5 Hangzhou Converd Co Ltd Recent Development
13.18 Hebei Senlang Biotechnology Inc Ltd
10.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details
10.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview and Its Total Revenue
10.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Introduction
10.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Development
13.19 HRAIN Biotechnology Co Ltd
10.19.1 HRAIN Biotechnology Co Ltd Company Details
10.19.2 HRAIN Biotechnology Co Ltd Business Overview and Its Total Revenue
10.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Introduction
10.19.4 HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.19.5 HRAIN Biotechnology Co Ltd Recent Development
13.20 Juno Therapeutics Inc
10.20.1 Juno Therapeutics Inc Company Details
10.20.2 Juno Therapeutics Inc Business Overview and Its Total Revenue
10.20.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Introduction
10.20.4 Juno Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.20.5 Juno Therapeutics Inc Recent Development
13.21 Kite Pharma Inc
10.21.1 Kite Pharma Inc Company Details
10.21.2 Kite Pharma Inc Business Overview and Its Total Revenue
10.21.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Introduction
10.21.4 Kite Pharma Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.21.5 Kite Pharma Inc Recent Development
13.22 Nanjing Legend Biotech Co Ltd
10.22.1 Nanjing Legend Biotech Co Ltd Company Details
10.22.2 Nanjing Legend Biotech Co Ltd Business Overview and Its Total Revenue
10.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Introduction
10.22.4 Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.22.5 Nanjing Legend Biotech Co Ltd Recent Development
13.23 NantKwest Inc
10.23.1 NantKwest Inc Company Details
10.23.2 NantKwest Inc Business Overview and Its Total Revenue
10.23.3 NantKwest Inc Adoptive Cellular Immunotherapy Introduction
10.23.4 NantKwest Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.23.5 NantKwest Inc Recent Development
13.24 Nkarta Inc
10.24.1 Nkarta Inc Company Details
10.24.2 Nkarta Inc Business Overview and Its Total Revenue
10.24.3 Nkarta Inc Adoptive Cellular Immunotherapy Introduction
10.24.4 Nkarta Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.24.5 Nkarta Inc Recent Development
13.25 Novartis AG
10.25.1 Novartis AG Company Details
10.25.2 Novartis AG Business Overview and Its Total Revenue
10.25.3 Novartis AG Adoptive Cellular Immunotherapy Introduction
10.25.4 Novartis AG Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.25.5 Novartis AG Recent Development
13.26 Ono Pharmaceutical Co Ltd
10.26.1 Ono Pharmaceutical Co Ltd Company Details
10.26.2 Ono Pharmaceutical Co Ltd Business Overview and Its Total Revenue
10.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Introduction
10.26.4 Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.26.5 Ono Pharmaceutical Co Ltd Recent Development
13.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
10.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
10.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview and Its Total Revenue
10.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Introduction
10.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Development
13.28 Sorrento Therapeutics Inc
10.28.1 Sorrento Therapeutics Inc Company Details
10.28.2 Sorrento Therapeutics Inc Business Overview and Its Total Revenue
10.28.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Introduction
10.28.4 Sorrento Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.28.5 Sorrento Therapeutics Inc Recent Development
13.29 Takara Bio Inc
10.29.1 Takara Bio Inc Company Details
10.29.2 Takara Bio Inc Business Overview and Its Total Revenue
10.29.3 Takara Bio Inc Adoptive Cellular Immunotherapy Introduction
10.29.4 Takara Bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020)
10.29.5 Takara Bio Inc Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Adoptive Cellular Immunotherapy Key Market Segments
Table 2. Key Players Covered: Ranking by Adoptive Cellular Immunotherapy Revenue
Table 3. Ranking of Global Top Adoptive Cellular Immunotherapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Adoptive Cellular Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of TIL
Table 6. Key Players of LAK
Table 7. Key Players of CAR-T
Table 8. Key Players of TCR-T
Table 9. Key Players of CIK
Table 10. Key Players of NK
Table 11. Key Players of DC
Table 12. Key Players of Other
Table 13. COVID-19 Impact Global Market: (Four Adoptive Cellular Immunotherapy Market Size Forecast Scenarios)
Table 14. Opportunities and Trends for Adoptive Cellular Immunotherapy Players in the COVID-19 Landscape
Table 15. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 16. Key Regions/Countries Measures against Covid-19 Impact
Table 17. Proposal for Adoptive Cellular Immunotherapy Players to Combat Covid-19 Impact
Table 18. Global Adoptive Cellular Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 19. Global Adoptive Cellular Immunotherapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 20. Global Adoptive Cellular Immunotherapy Market Size by Regions (2015-2020) (US$ Million)
Table 21. Global Adoptive Cellular Immunotherapy Market Share by Regions (2015-2020)
Table 22. Global Adoptive Cellular Immunotherapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 23. Global Adoptive Cellular Immunotherapy Market Share by Regions (2021-2026)
Table 24. Market Top Trends
Table 25. Key Drivers: Impact Analysis
Table 26. Key Challenges
Table 27. Adoptive Cellular Immunotherapy Market Growth Strategy
Table 28. Main Points Interviewed from Key Adoptive Cellular Immunotherapy Players
Table 29. Global Adoptive Cellular Immunotherapy Revenue by Players (2015-2020) (Million US$)
Table 30. Global Adoptive Cellular Immunotherapy Market Share by Players (2015-2020)
Table 31. Global Top Adoptive Cellular Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adoptive Cellular Immunotherapy as of 2019)
Table 32. Global Adoptive Cellular Immunotherapy by Players Market Concentration Ratio (CR5 and HHI)
Table 33. Key Players Headquarters and Area Served
Table 34. Key Players Adoptive Cellular Immunotherapy Product Solution and Service
Table 35. Date of Enter into Adoptive Cellular Immunotherapy Market
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 38. Global Adoptive Cellular Immunotherapy Market Size Share by Type (2015-2020)
Table 39. Global Adoptive Cellular Immunotherapy Revenue Market Share by Type (2021-2026)
Table 40. Global Adoptive Cellular Immunotherapy Market Size Share by Application (2015-2020)
Table 41. Global Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 42. Global Adoptive Cellular Immunotherapy Market Size Share by Application (2021-2026)
Table 43. North America Key Players Adoptive Cellular Immunotherapy Revenue (2019-2020) (Million US$)
Table 44. North America Key Players Adoptive Cellular Immunotherapy Market Share (2019-2020)
Table 45. North America Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 46. North America Adoptive Cellular Immunotherapy Market Share by Type (2015-2020)
Table 47. North America Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 48. North America Adoptive Cellular Immunotherapy Market Share by Application (2015-2020)
Table 49. Europe Key Players Adoptive Cellular Immunotherapy Revenue (2019-2020) (Million US$)
Table 50. Europe Key Players Adoptive Cellular Immunotherapy Market Share (2019-2020)
Table 51. Europe Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 52. Europe Adoptive Cellular Immunotherapy Market Share by Type (2015-2020)
Table 53. Europe Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 54. Europe Adoptive Cellular Immunotherapy Market Share by Application (2015-2020)
Table 55. China Key Players Adoptive Cellular Immunotherapy Revenue (2019-2020) (Million US$)
Table 56. China Key Players Adoptive Cellular Immunotherapy Market Share (2019-2020)
Table 57. China Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 58. China Adoptive Cellular Immunotherapy Market Share by Type (2015-2020)
Table 59. China Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 60. China Adoptive Cellular Immunotherapy Market Share by Application (2015-2020)
Table 61. Japan Key Players Adoptive Cellular Immunotherapy Revenue (2019-2020) (Million US$)
Table 62. Japan Key Players Adoptive Cellular Immunotherapy Market Share (2019-2020)
Table 63. Japan Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 64. Japan Adoptive Cellular Immunotherapy Market Share by Type (2015-2020)
Table 65. Japan Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 66. Japan Adoptive Cellular Immunotherapy Market Share by Application (2015-2020)
Table 67. Southeast Asia Key Players Adoptive Cellular Immunotherapy Revenue (2019-2020) (Million US$)
Table 68. Southeast Asia Key Players Adoptive Cellular Immunotherapy Market Share (2019-2020)
Table 69. Southeast Asia Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 70. Southeast Asia Adoptive Cellular Immunotherapy Market Share by Type (2015-2020)
Table 71. Southeast Asia Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 72. Southeast Asia Adoptive Cellular Immunotherapy Market Share by Application (2015-2020)
Table 73. India Key Players Adoptive Cellular Immunotherapy Revenue (2019-2020) (Million US$)
Table 74. India Key Players Adoptive Cellular Immunotherapy Market Share (2019-2020)
Table 75. India Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 76. India Adoptive Cellular Immunotherapy Market Share by Type (2015-2020)
Table 77. India Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 78. India Adoptive Cellular Immunotherapy Market Share by Application (2015-2020)
Table 79. Central & South America Key Players Adoptive Cellular Immunotherapy Revenue (2019-2020) (Million US$)
Table 80. Central & South America Key Players Adoptive Cellular Immunotherapy Market Share (2019-2020)
Table 81. Central & South America Adoptive Cellular Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 82. Central & South America Adoptive Cellular Immunotherapy Market Share by Type (2015-2020)
Table 83. Central & South America Adoptive Cellular Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 84. Central & South America Adoptive Cellular Immunotherapy Market Share by Application (2015-2020)
Table 85. Amgen Inc Company Details
Table 86. Amgen Inc Business Overview
Table 87. Amgen Inc Product
Table 88. Amgen Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 89. Amgen Inc Recent Development
Table 90. Autolus Therapeutics Plc Company Details
Table 91. Autolus Therapeutics Plc Business Overview
Table 92. Autolus Therapeutics Plc Product
Table 93. Autolus Therapeutics Plc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 94. Autolus Therapeutics Plc Recent Development
Table 95. Beijing Immunochina Medical Science & Technology Co Ltd Company Details
Table 96. Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
Table 97. Beijing Immunochina Medical Science & Technology Co Ltd Product
Table 98. Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 99. Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
Table 100. Bellicum Pharmaceuticals Inc Company Details
Table 101. Bellicum Pharmaceuticals Inc Business Overview
Table 102. Bellicum Pharmaceuticals Inc Product
Table 103. Bellicum Pharmaceuticals Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 104. Bellicum Pharmaceuticals Inc Recent Development
Table 105. Bristol-Myers Squibb Co Company Details
Table 106. Bristol-Myers Squibb Co Business Overview
Table 107. Bristol-Myers Squibb Co Product
Table 108. Bristol-Myers Squibb Co Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 109. Bristol-Myers Squibb Co Recent Development
Table 110. bluebird bio Inc Company Details
Table 111. bluebird bio Inc Business Overview
Table 112. bluebird bio Inc Product
Table 113. bluebird bio Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 114. bluebird bio Inc Recent Development
Table 115. CARsgen Therapeutics Ltd Company Details
Table 116. CARsgen Therapeutics Ltd Business Overview
Table 117. CARsgen Therapeutics Ltd Product
Table 118. CARsgen Therapeutics Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 119. CARsgen Therapeutics Ltd Recent Development
Table 120. Celgene Corp Business Overview
Table 121. Celgene Corp Product
Table 122. Celgene Corp Company Details
Table 123. Celgene Corp Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 124. Celgene Corp Recent Development
Table 125. Cell Medica Ltd Company Details
Table 126. Cell Medica Ltd Business Overview
Table 127. Cell Medica Ltd Product
Table 128. Cell Medica Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 129. Cell Medica Ltd Recent Development
Table 130. Cellular Biomedicine Group Inc Company Details
Table 131. Cellular Biomedicine Group Inc Business Overview
Table 132. Cellular Biomedicine Group Inc Product
Table 133. Cellular Biomedicine Group Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 134. Cellular Biomedicine Group Inc Recent Development
Table 135. Celularity Inc Company Details
Table 136. Celularity Inc Business Overview
Table 137. Celularity Inc Product
Table 138. Celularity Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 139. Celularity Inc Recent Development
Table 140. Celyad SA Company Details
Table 141. Celyad SA Business Overview
Table 142. Celyad SA Product
Table 143. Celyad SA Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 144. Celyad SA Recent Development
Table 145. Daiichi Sankyo Co Ltd Company Details
Table 146. Daiichi Sankyo Co Ltd Business Overview
Table 147. Daiichi Sankyo Co Ltd Product
Table 148. Daiichi Sankyo Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 149. Daiichi Sankyo Co Ltd Recent Development
Table 150. Fosun Pharmaceutical AG Company Details
Table 151. Fosun Pharmaceutical AG Business Overview
Table 152. Fosun Pharmaceutical AG Product
Table 153. Fosun Pharmaceutical AG Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 154. Fosun Pharmaceutical AG Recent Development
Table 155. Gilead Sciences Inc Company Details
Table 156. Gilead Sciences Inc Business Overview
Table 157. Gilead Sciences Inc Product
Table 158. Gilead Sciences Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 159. Gilead Sciences Inc Recent Development
Table 160. Guangzhou Anjie Biomedical Technology Co Ltd Company Details
Table 161. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
Table 162. Guangzhou Anjie Biomedical Technology Co Ltd Product
Table 163. Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 164. Guangzhou Anjie Biomedical Technology Co Ltd Recent Development
Table 165. Hangzhou Converd Co Ltd Company Details
Table 166. Hangzhou Converd Co Ltd Business Overview
Table 167. Hangzhou Converd Co Ltd Product
Table 168. Hangzhou Converd Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 169. Hangzhou Converd Co Ltd Recent Development
Table 170. Hebei Senlang Biotechnology Inc Ltd Company Details
Table 171. Hebei Senlang Biotechnology Inc Ltd Business Overview
Table 172. Hebei Senlang Biotechnology Inc Ltd Product
Table 173. Hebei Senlang Biotechnology Inc Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 174. Hebei Senlang Biotechnology Inc Ltd Recent Development
Table 175. HRAIN Biotechnology Co Ltd Company Details
Table 176. HRAIN Biotechnology Co Ltd Business Overview
Table 177. HRAIN Biotechnology Co Ltd Product
Table 178. HRAIN Biotechnology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 179. HRAIN Biotechnology Co Ltd Recent Development
Table 180. Juno Therapeutics Inc Company Details
Table 181. Juno Therapeutics Inc Business Overview
Table 182. Juno Therapeutics Inc Product
Table 183. Juno Therapeutics Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 184. Juno Therapeutics Inc Recent Development
Table 185. Kite Pharma Inc Company Details
Table 186. Kite Pharma Inc Business Overview
Table 187. Kite Pharma Inc Product
Table 188. Kite Pharma Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 189. Kite Pharma Inc Recent Development
Table 190. Nanjing Legend Biotech Co Ltd Company Details
Table 191. Nanjing Legend Biotech Co Ltd Business Overview
Table 192. Nanjing Legend Biotech Co Ltd Product
Table 193. Nanjing Legend Biotech Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 194. Nanjing Legend Biotech Co Ltd Recent Development
Table 195. NantKwest Inc Company Details
Table 196. NantKwest Inc Business Overview
Table 197. NantKwest Inc Product
Table 198. NantKwest Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 199. NantKwest Inc Recent Development
Table 200. Nkarta Inc Company Details
Table 201. Nkarta Inc Business Overview
Table 202. Nkarta Inc Product
Table 203. Nkarta Inc Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 204. Nkarta Inc Recent Development
Table 205. Novartis AG Company Details
Table 206. Novartis AG Business Overview
Table 207. Novartis AG Product
Table 208. Novartis AG Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 209. Novartis AG Recent Development
Table 210. Ono Pharmaceutical Co Ltd Company Details
Table 211. Ono Pharmaceutical Co Ltd Business Overview
Table 212. Ono Pharmaceutical Co Ltd Product
Table 213. Ono Pharmaceutical Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 214. Ono Pharmaceutical Co Ltd Recent Development
Table 215. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
Table 216. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
Table 217. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Product
Table 218. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Adoptive Cellular Immunotherapy Business (2015-2020) (Million US$)
Table 219. Shanghai Unicar-Therapy Bi

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs